التفاصيل البيبلوغرافية
العنوان:
Neuro-inflammatory risk factors for treatment failure in 'early second stage' sleeping sickness patients treated with Pentamidine
المؤلفون:
Marc Gastellu Etchegorry , Alexia Savignoni , Dawson Mbulamberi , Veerle Lejon , Dominique Legros , Philippe Büscher
سنة النشر:
2003
مصطلحات موضوعية:
Male , Trypanosoma brucei gambiense , Melarsoprol , Intrathecal humoral immune response , Treatment failure , law.invention , Leukocyte Count , Cerebrospinal fluid , Randomized controlled trial , law , Recurrence , Risk Factors , Immunology and Allergy , Stage (cooking) , Child , Intrathecal immunoglobulin synthesis , Cerebrospinal Fluid Proteins , Middle Aged , Protozoal diseases , Card agglutination test , Latex fixation test , Neurology , Child, Preschool , Female , Brain involvement , medicine.drug , Adult , medicine.medical_specialty , IgM , Adolescent , Efficacy , Immunology , Internal medicine , parasitic diseases , medicine , Animals , Humans , Pentamidine , business.industry , medicine.disease , Clinical trial , Trypanosomiasis, African , Immunoglobulin M , Neurology (clinical) , business , Trypanosomiasis , Latex Fixation Tests
الوصف:
In a clinical trial on efficacy of Pentamidine in second stage Trypanosoma brucei gambiense patients with /=4 and LATEX/T.b. gambiense positive CSF, were associated with treatment failure.Detection of intrathecal IgM synthesis is valuable for assessment of brain involvement and treatment decision.
اللغة:
English
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a8db14957f1697acf5d5190b420b6c http://193.190.39.98/bitstream/10390/07/1/pp2003jneu0132.pdf
حقوق:
OPEN
رقم الأكسشن:
edsair.doi.dedup.....16a8db14957f1697acf5d5190b420b6c
قاعدة البيانات:
OpenAIRE
